Evidence is presented for the charge-exchange photoproduction, in two distinct reactions, of an isovector ρπ state of mass ∼1775 MeV. Results of an analysis of the decay-angular distributions are also presented, from which it is concluded that =, , or .
We have prepared a MAb, 7C4, which inhibits the RNA-dependent DNA polymerase activity of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT); this MAb has allowed identification of a previously unknown neutralizing epitope of RT. Analysis of the epitope and of the mechanism of polymerase inhibition revealed that 7C4 acts by interfering with the interaction between RT and the template-primer. 7C4 recognizes a discontinuous epitope on the two α-helices, αH and αI, that make up the ‘thumb’ subdomain of RT. The existing crystallographic model of HIV-1 RT suggests that the ‘thumb’ subdomain, together with the ‘fingers’ and ‘palm’, form a nucleic-acid-binding cleft in the 66 kDa subunit of RT and that αH is in contact with the primer strand of the template-primer. The extent of inhibition of enzyme activity produced by 7C4 correlates with the reported primer-length-dependency of template-primer binding to RT. Inhibition by 7C4 was competitive with respect to the template-primer and mixed with respect to the substrate. Binding of 7C4 to RT was prevented by preincubation of the enzyme with high concentrations of template-primer but not with substrate. Thus, the 7C4 epitope apparently exists on part of the template-primer binding site of the αH and αI regions of the ‘thumb’ subdomain. This neutralization epitope is a logical target for the development of new types of HIV-1 RT inhibitors.
Background: Postinfarct ventricular septal defect (PIVSD) is a serious complication of acute myocardial infarction (AMI). Transcatheter closure is a potential alternative to surgical closure for PIVSD patients.Objective: This meta‐analysis compares the clinical outcomes of transcatheter closure versus surgical closure for PIVSD.Methods: A systemic search of PubMed and Embase until January 2023 identified studies comparing transcatheter versus surgical PIVSD closure. Primary outcomes included short‐term mortality. Short‐term mortality referred to the number of in‐hospital or 30‐day deaths. Secondary outcomes comprised residual shunt/reintervention incidence, difference in time from AMI or PIVSD diagnosis to intervention, the presence of cardiogenic shock, incidence of perioperative mechanical support, PIVSD size difference, and overall mortality at follow‐up.Results: Seven studies comprising 603 patients were included. Short‐term mortality (OR, 1.30; 95% CI [0.90, 1.89]; p = 0.17; I2 = 3.0%) did not significantly differ between the two groups. The incidence of residual shunt/reintervention (OR, 3.56; CI, 1.33–9.59; p = 0.01; I2 = 63.0%) and PIVSD size (mean difference, −3.94 mm; CI [−6.90, −0.99]; p = 0.09; I2 = 83.0%) were significantly different; however, the other secondary outcomes were not significantly different.Conclusion: Transcatheter and surgical closure demonstrate similar short‐term mortality. Despite a higher incidence of residual shunt or reintervention in transcatheter closure, it may be a viable option in patients with small size of PIVSD.
The 2018 heart allocation system has significantly influenced heart transplantation and left ventricular assist device (LVAD) utilization. Our study aims to investigate age-related outcomes following LVAD implantation in the post-allocation era. Using the National Inpatient Sample, we analyzed data from 7375 patients who underwent LVAD implantation between 2019 and 2020. The primary endpoint was in-hospital mortality following LVAD implantation, stratified by age categories. The age groups were 18–49, 50–59, 60–69, and over 70. These represented 26%, 26%, 31%, and 17% of patients, respectively. Patients aged 60–69 and those over 70 exhibited higher in-hospital mortality rates of 12% and 17%, respectively, compared to younger age groups (7% for 18–49 and 6% for 50–59). The age groups 60–69 and over 70 were independent predictors of mortality, with adjusted odds ratios of 1.99 (p = 0.02; 95% confidence interval [CI], 1.12–3.57) and 2.88 (p = 0.002; 95% CI, 1.45–5.71), respectively. Additionally, a higher Charlson Comorbidity Index was associated with increased in-hospital mortality risk (adjusted odds ratio 1.39; p = 0.02; 95% CI, 1.05–1.84). Additionally, patients above 70 experienced a statistically shorter length of stay. Nonhome discharge was found to be significantly high across all age categories. However, the difference in hospitalization cost was not statistically significant across the age groups. Our study highlights that patients aged 60 and above face an increased risk of in-hospital mortality following LVAD implantation in the post-allocation era. This study sheds light on age-related outcomes and emphasizes the importance of considering age in LVAD patient selection and management strategies.
1 January 1999 in Journal of the Japan Veterinary Medical Association
Ozonated autohemotherapy was applied to 27 cows with incurable ananastasia and dysstasia due to arthritis, laminitis, post dystocic neuroparalysis and Downer syndrome. Seventeen of 27 (63%) treated cows recovered showing obvious lentitive effect and smooth standing action as well as significantly decreased levels of serum GOT and CPK activities.
1 January 1994 in Japanese Journal of Oral and Maxillofacial Surgery
We reported eight cases of tuberculous cervical lymphadenitis encountered at our clinic during the period from 1978 to 1993. They consisted of three males and five females ranging in age from 7 to 75 years old. The clinical diagnosis was a tumor-like lesion in three cases and a strong suspicion of tuberculous cervical lympnadenitis in four cases; five of these cases were diagnosed as cervical lymphadenitis based on clinical evidence. Regarding treatment, surgery alone was used in two cases, and chemotherapy after surgery was employed in six cases. All resected specimens were histopathologically diagnosed as tuberculous lymphadenitis. The diagnosis of tuberculous cervical lymphadenitis is difficult to make on a clinical basis. Open biopsy of the cervical lymph nodes played an important role in the diagnosis of tuberculous cervical lymphadenitis.